We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
-3.11%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$722M
AUM Growth
-$85.3M
Cap. Flow
-$23.1M
Cap. Flow %
-3.19%
Top 10 Hldgs %
36.06%
Holding
97
New
24
Increased
24
Reduced
14
Closed
32

Top Buys

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$23M
2
DXCM icon
DexCom
DXCM
+$19.7M
3
MDT icon
Medtronic
MDT
+$18.4M
4
BDX icon
Becton Dickinson
BDX
+$17.6M
5
AMGN icon
Amgen
AMGN
+$16.2M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$34.2M
2
ZBH icon
Zimmer Biomet
ZBH
+$29.2M
3
COO icon
Cooper Companies
COO
+$13.6M
4
CNC icon
Centene
CNC
+$13.5M
5
ABBV icon
AbbVie
ABBV
+$13.5M

Sector Composition

Rank Sector Weight
1 Healthcare 97.17%
2 Consumer Discretionary 0.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIBN icon
26
SI-BONE Inc
SIBN
$843M
$10.3M 1.43%
485,000
+258,000
+114% +$5.98M
TEVA icon
27
Teva Pharmaceuticals
TEVA
$42.5B
$10.2M 1.41%
1,000,000
– –
GH icon
28
Guardant Health
GH
$22.2B
$9.63M 1.33%
325,000
-87,000
-21% -$3.06M
NBIX icon
29
Neurocrine Biosciences
NBIX
$16.5B
$9.56M 1.32%
+85,000
New +$8.95M
ZNTL icon
30
Zentalis Pharmaceuticals
ZNTL
$295M
$9.03M 1.25%
450,000
– –
LFST icon
31
Lifestance Health
LFST
$4.39B
$8.93M 1.24%
1,300,000
+527,000
+68% +$4.27M
VKTX icon
32
Viking Therapeutics
VKTX
$3.94B
$8.86M 1.23%
800,000
+70,000
+10% +$1M
NTRA icon
33
Natera
NTRA
$45.1B
$8.85M 1.23%
+200,000
New +$10.2M
HOLX
34
DELISTED
Hologic
HOLX
$8.68M 1.2%
125,000
-50,000
-29% -$3.78M
MLTX icon
35
PUT
MoonLake Immunotherapeutics
MLTX
$1.41B
$8.55M 1.18%
+150,000
New +$8.28M
ELAN icon
36
Elanco Animal Health
ELAN
$11.4B
$8.41M 1.16%
748,000
+548,000
+274% +$6.36M
KRYS icon
37
Krystal Biotech
KRYS
$9.68B
$8.12M 1.12%
70,000
+8,000
+13% +$976K
ZBH icon
38
Zimmer Biomet
ZBH
$18.5B
$7.86M 1.09%
70,000
-230,000
-77% -$29.2M
ALKS icon
39
Alkermes
ALKS
$8.26B
$7.7M 1.07%
275,000
-9,000
-3% -$264K
CTLT
40
DELISTED
CATALENT, INC.
CTLT
$7.28M 1.01%
+160,000
New +$7.48M
BBIO icon
41
BridgeBio Pharma
BBIO
$16.4B
$7.25M 1%
+275,000
New +$7.8M
ITCI
42
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.93M 0.96%
133,000
-9,000
-6% -$524K
RLAY icon
43
Relay Therapeutics
RLAY
$4.38B
$6.73M 0.93%
800,000
+100,000
+14% +$1.08M
PACB icon
44
Pacific Biosciences
PACB
$354M
$6.68M 0.92%
+800,000
New +$9.14M
SUPN icon
45
Supernus Pharmaceuticals
SUPN
$2.73B
$6.07M 0.84%
220,000
+145,000
+193% +$4.41M
SRPT icon
46
CALL
Sarepta Therapeutics
SRPT
$1.92B
$6.06M 0.84%
+50,000
New +$5.65M
CRNX icon
47
Crinetics Pharmaceuticals
CRNX
$8.95B
$5.95M 0.82%
+200,000
New +$4.12M
WBA
48
DELISTED
Walgreens Boots Alliance
WBA
$5.56M 0.77%
+250,000
New +$6.65M
ROIV icon
49
Roivant Sciences
ROIV
$25.5B
$5.26M 0.73%
+450,000
New +$5.09M
MRK icon
50
Merck
MRK
$322B
$5.15M 0.71%
+50,000
New +$5.39M
1
2
3 4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Integral Health Asset Management held 97 positions worth $722M, down 11% from $808M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Integral Health Asset Management withdrew a net $23.1M in Q3 2023, closing 32 positions and reducing 14 holdings. Its most notable exit was Centene, an estimated $13.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 94% a quarter earlier, followed by Consumer Discretionary.

Against the trend, Integral Health Asset Management opened a new position in DexCom worth $16.3M.

  • Integral Health Asset Management's largest Q3 2023 buy was DexCom: 175,000 shares worth $16.3M.
  • Integral Health Asset Management added most to Tenet Healthcare in Q3 2023, an estimated $23M increase.
  • Integral Health Asset Management's biggest Q3 2023 reduction was Cigna, cutting an estimated $34.2M.
  • Integral Health Asset Management fully exited Centene in Q3 2023, selling an estimated $13.5M.
  • Integral Health Asset Management's ten largest holdings make up 36% of its $722M portfolio in Q3 2023.
  • Integral Health Asset Management opened 24 new positions and closed 32 in Q3 2023.
  • Integral Health Asset Management's portfolio value fell 11% quarter-over-quarter to $722M.

Based on Integral Health Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.